Cargando…
Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma
The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen’s disease, as well...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528745/ https://www.ncbi.nlm.nih.gov/pubmed/32772261 http://dx.doi.org/10.1007/s00403-020-02114-w |
_version_ | 1784586313761030144 |
---|---|
author | Korhonen, Niina Ylitalo, Leea Luukkaala, Tiina Itkonen, Julius Häihälä, Henni Jernman, Juha Snellman, Erna Palve, Johanna |
author_facet | Korhonen, Niina Ylitalo, Leea Luukkaala, Tiina Itkonen, Julius Häihälä, Henni Jernman, Juha Snellman, Erna Palve, Johanna |
author_sort | Korhonen, Niina |
collection | PubMed |
description | The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen’s disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006–2015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (n = 164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6 years less than that of the patients with premalignant lesions (p < 0.001) or BCC (p < 0.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3 mm, interquartile range 2–6) than in those with premalignant lesions or BCC (median 2 mm, interquartile range 1–3), p < 0.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up. |
format | Online Article Text |
id | pubmed-8528745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85287452021-11-04 Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma Korhonen, Niina Ylitalo, Leea Luukkaala, Tiina Itkonen, Julius Häihälä, Henni Jernman, Juha Snellman, Erna Palve, Johanna Arch Dermatol Res Concise Communication The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen’s disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006–2015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (n = 164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6 years less than that of the patients with premalignant lesions (p < 0.001) or BCC (p < 0.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3 mm, interquartile range 2–6) than in those with premalignant lesions or BCC (median 2 mm, interquartile range 1–3), p < 0.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up. Springer Berlin Heidelberg 2020-08-09 2021 /pmc/articles/PMC8528745/ /pubmed/32772261 http://dx.doi.org/10.1007/s00403-020-02114-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Concise Communication Korhonen, Niina Ylitalo, Leea Luukkaala, Tiina Itkonen, Julius Häihälä, Henni Jernman, Juha Snellman, Erna Palve, Johanna Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title | Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title_full | Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title_fullStr | Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title_full_unstemmed | Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title_short | Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
title_sort | premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma |
topic | Concise Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528745/ https://www.ncbi.nlm.nih.gov/pubmed/32772261 http://dx.doi.org/10.1007/s00403-020-02114-w |
work_keys_str_mv | AT korhonenniina premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT ylitaloleea premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT luukkaalatiina premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT itkonenjulius premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT haihalahenni premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT jernmanjuha premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT snellmanerna premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma AT palvejohanna premalignantlesionsbasalcellcarcinomaandmelanomainpatientswithcutaneoussquamouscellcarcinoma |